We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

CTAS:NASDAQCintas Corporation Analysis

Data as of 2026-08-20 - not real-time

$203.08

Latest Price

4/10Risk

Risk Level: Medium

Executive Summary

The moving-average structure behind Cintas Corporation is bullish at $203.08, with short-term averages leading the long-term ones. It has gained 12.7% over the past 30 days. RSI sits at 56.2, which reads as neutral, and MACD momentum is bearish. Watch $196.50 as support and $219.17 as the nearer resistance level.
On valuation the read is overvalued — earnings multiple of 40.6 versus a 30.2 sector average, above the peer group. Consensus targets land 6.5% above where the shares trade now. Revenue is growing at 8.9% on a 17.8% profit margin. The 1.04% dividend yield looks covered by current payout levels.
The composite risk read is 4/10, putting it in moderate territory. With 30-day volatility of 32.2%, a beta of 0.18 and a maximum drawdown of 24.5%, position sizing matters here. The wider market backdrop reads extreme greed at 95 on the fear-greed composite.
All three time horizons resolve to hold, carrying 2/10 conviction.

Top Market Events

Cintas Corp CTAS reports robust growth with an 8.Cintas Corp CTAS reports robust growth with an 8.Uniform and facility services provider Cintas NASDAQ:CTAS reported Q2 CY2026 results , with sales up 8.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • Trading above the 200-day average of 185.77
  • MACD momentum is negative

Medium Term

1–3 years
Neutral
Model confidence: 3/10

Key Factors

  • Short-term moving averages stacked above long-term ones
  • P/E of 40.6 versus sector average of 30.2
  • Trading above the 200-day average of 185.77

Long Term

> 3 years
Neutral
Model confidence: 2/10

Key Factors

  • P/E of 40.6 versus sector average of 30.2
  • Analyst targets imply +6.5% versus the current price
  • Profit margin of 17.8% is healthy

Key Metrics & Analysis

Financial Health

Revenue Growth8.90%
Profit Margin17.75%
P/E Ratio40.6
ROE40.71%
ROA16.10%
Debt/Equity52.65
P/B Ratio15.8
Op. Cash Flow$2.3B
Free Cash Flow$1.5B
Industry P/E30.2

Technical Analysis

TrendBullish
RSI56.2
Support$196.50
Resistance$219.17
MA 20$204.47
MA 50$190.34
MA 200$185.77
MACDBearish
VolumeDecreasing
Fear & Greed Index94.7

Valuation

Fair Value$61.99
Target Price$216.31
Upside/Downside6.52%
GradeOvervalued
TypeGrowth
Dividend Yield1.04%

Risk Assessment

Beta0.18
Volatility32.19%
Sector RiskMedium
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.